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The diagnosis of transient ischemic attack (TIA) can be no-toriously difficult, mainly because it is often solely based 
on history taking. Patients suspected of a TIA require an urgent 
assessment with timely start of antithrombotic therapy to re-
duce the risk of an early ischemic stroke.1 However, even after 
careful evaluation at a TIA service, the final diagnosis made 
by the neurologist often holds a degree of uncertainty.2 Both 
excluding and confirming a TIA can be difficult and, there-
fore, underdiagnosis as well as overdiagnosis are common.
Strict criteria for the diagnosis of TIA do not exist. In 
clinical practice and research, the diagnosis is usually at the 
discretion of the treating physician without specific require-
ments with respect to the type of neurological symptoms and 
deficits. Attempts have been made to facilitate the diagnosis 
of TIA by creating a diagnostic score based on multivariable 
logistic regression modeling.3,4 Yet, these scores did not find 
their way to the clinic, probably because they are not feasible 
in clinical practice considering the large number of items in-
cluded in the scores. Most importantly, these scores are not 
sufficiently accurate to confirm or rule out TIA.5
Skeptics state that possible symptoms and signs of a TIA 
are too heterogeneous to create a useful diagnostic score. 
Background and Purpose—The clinical diagnosis of a transient ischemic attack (TIA) can be difficult. Evidence-based 
criteria hardly exist. We evaluated if the recently proposed Explicit Diagnostic Criteria for TIA (EDCT), an easy to 
perform clinical tool focusing on type, duration, and mode of onset of clinical features, would facilitate the clinical 
diagnosis of TIA.
Methods—We used data from patients suspected of a TIA by a general practitioner and referred to a TIA service in the region 
of Utrecht, the Netherlands, who participated in the MIND-TIA (Markers in the Diagnosis of TIA) study. Information 
about the clinical features was collected with a standardized questionnaire within 72 hours after onset. A panel of 3 
experienced neurologists ultimately determined the definite diagnosis based on all available diagnostic information 
including a 6-month follow-up period. Two researchers scored the EDCT. Sensitivity, specificity, and predictive values 
of the EDCT were assessed using the panel diagnosis as reference. A secondary analysis was performed with modified 
subcriteria of the EDCT.
Results—Of the 206 patients, 126 (61%) had a TIA (n=104) or minor stroke (n=22), and 80 (39%) an alternative diagnosis. 
Most common alternative diagnoses were migraine with aura (n=24; 30.0%), stress related or somatoform symptoms 
(n=16; 20.0%), and syncope (n=9; 11.3%). The original EDCT had a sensitivity of 98.4% (95% CI, 94.4–99.8) and a 
specificity of 61.3% (49.7–71.9). Negative and positive predictive values were 96.1% (86.0–99.0) and 80.0% (75.2–84.1), 
respectively. The modified EDCT showed a higher specificity of 73.8% (62.7–83.0) with the same sensitivity and a 
similar negative predictive value of 96.7%, but a higher positive predictive value of 85.5% (80.3–89.5).
Conclusions—The EDCT has excellent sensitivity and negative predictive value and could be a valuable diagnostic tool for 
the diagnosis of TIA.   (Stroke. 2019;50:2080-2085. DOI: 10.1161/STROKEAHA.119.025626.)
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Still, recently, 2 of us (E.R. Lebedeva and J. Olesen) devel-
oped a set of Explicit Diagnostic Criteria for TIA (EDCT) 
based on clinical practice and experience instead of statis-
tical methods.6 The criteria were originally developed with a 
focus on the discrimination between TIA and migraine with 
aura, one of its most common mimics. As a first step, the per-
formance of these criteria was evaluated in separate cohorts 
of patients with TIA or with migraine with aura. EDCT cor-
rectly classified 99% of TIAs and 95% of migraine with aura 
cases (as non-TIA). The criteria have, however, not been vali-
dated in the clinically relevant domain of patients suspected 
of TIA. In case the EDCT correctly classifies those with and 
without TIA, diagnostic management of these patients could 
be improved considerably. Thus, we evaluated the diagnostic 
value of EDCT criteria in patients with suspected TIA.
Methods
The authors declare that all supporting data are available within the 
article.
The criteria of the EDCT are summarized in Table 1. We used 
the MIND-TIA (Markers in the Diagnosis of TIA) cohort to validate 
the accuracy of the EDCT.7 This cohort consists of 206 patients sus-
pected of a TIA by their general practitioner (GP), who were evalu-
ated between September 2013 and September 2016, in the region of 
Utrecht, the Netherlands. All participants were referred by their GP 
to a regional TIA service for evaluation by a neurologist and ancillary 
investigations, including brain imaging. Signs and symptoms were re-
corded with a standardized questionnaire filled out by a research nurse 
within 72 hours after onset (see the online-only Data Supplement). In 
addition, a taped narrative of the patient was collected. Thus, a prede-
fined set of variables could be obtained per participant.
Assessment of the EDCT
The data gathered in the MIND-TIA study provided all necessary in-
formation for classification according to the criteria of the EDCT. 
For each participant, we double-checked the data retrieved from 
the standardized questionnaire with the correspondence of the con-
sulting neurologist and the of GP (D. Veluponnar). In case any doubt 
about the scoring or discrepancy between the results of the research 
nurse’s interview and the correspondence, a second researcher (Dr 
Dolmans) also made a judgment. If there was discrepancy between 
the 2 researchers, a third researcher (Dr Kappelle) was asked for the 
majority vote. Also, one of us (Dr Dolmans) checked the scoring of 
(1) all cases in which the EDCT came to another diagnosis than the 
expert panel standard and (2) a random sample of 20% of all cases.
We also included the cases that had a final diagnosis of minor dis-
abling stroke. These cases of minor strokes had to fulfill the essential 
criteria A, C, and D but were allowed to not fulfill criteria B (duration 
<24 hours) and E (absence of infarction on imaging; Table 1).
Panel Diagnosis
An expert panel consisting of 3 experienced stroke neurologists (Dr 
Nederkoorn, Dr van Dijk, and Dr Kappelle) determined the definite 
diagnosis, using all information from the following: (1) the standard-
ized questionnaire; (2) a taped patient’s narrative of the event; (3) the 
correspondence of the GP; (4) the discharge letters from the treating 
neurologist, and other specialists if attended; (5) the results of the 
ancillary investigations, including brain imaging (computed tomog-
raphy, magnetic resonance imaging, or both); and (6) a 6-month fol-
low-up period.
The expert panel determined whether patients had a TIA or minor 
disabling stroke, or an alternative diagnosis, applying the time-based 
definition of TIA.8 The panel members first assessed all cases indi-
vidually and estimated the probability of a TIA on a visual analogue 
scale. Consensus on the diagnosis of TIA was assumed if all 3 neu-
rologists similarly scored the probability of TIA ≤20% or ≥80%. All 
other cases were discussed in a panel meeting, and a final judgement 
was based on a majority of votes.
Data Analysis
We assessed the diagnostic accuracy of the EDCT (sensitivity, speci-
ficity, predictive values and c-statistic, with 95% CIs), with the panel 
diagnosis as reference standard.
During the process of scoring, we recognized certain patterns in 
the assessment of the C-criterion that led to cases falsely identified as 
TIA. Therefore, and also to reduce the chance of misinterpretation by 
the user, we rephrased the original subcriteria C1-C3 (describing an 
onset in full intensity [C1], symptoms occurring simultaneously [C2], 
and the presence of actual neurological deficits), so that these apply 
to all symptoms instead of one or some of the symptoms (Table 1). 
As a secondary analysis, we also assessed the performance of this 
modified EDCT.
Ethical Approval
The MIND-TIA study has been approved by the Medical Research 
Ethics Committee of the University Medical Center of Utrecht, the 
Netherlands. All participants gave written informed consent.
Results
Of the 206 patients suspected of TIA by their GP, 126 (61%) 
participants had a TIA (n=104) or minor disabling stroke 
(n=22), and 80 (39%) patients had an alternative diagnosis 
according to the expert panel. Mean (SD) age was 67.7 (13.7) 
years and was higher among those with TIA/minor stroke than 
Table 1. Original EDCT and the Modified Subcriteria C1, C2, and C36
A Sudden onset of fully reversible neurological or retinal symptoms
(typically hemiparesis, hemihypesthesia, aphasia, neglect, 
amaurosis fugax, hemianopsia, or hemiataxia)
B Duration <24 h
C At least 2 of the following:
  At least 1 symptom is maximal in <1 min (no gradual spread)
  2 or more symptoms occur simultaneously
  Symptoms in the form of deficits (no irritative symptoms such 
as photopsias, pins, and needles, etc)
  No headache accompanies or follows the neurological 
symptoms within 1 h
C* At least 2 of the following:
  All symptoms are maximal in <1 min (no gradual spread)*
  All symptoms occur simultaneously*
  All symptoms are deficits (no irritative symptoms such as 
photopsias, pins, and needles, etc)*
  No headache accompanies or follows the neurological 
symptoms within 1 h*
D None of the following isolated symptoms (can occur together 
with more typical symptoms): shaking spells, diplopia, dizziness, 
vertigo, syncope, decreased level of consciousness, confusion, 
hyperventilation-associated paresthesia, unexplained falls, and 
amnesia
E No evidence of acute infarction in the relevant area on 
neuroimaging
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in those with an alternative diagnosis (71.4 [12.0] versus 62.0 
[14.2]; Table 2).
Migraine with aura was the most common alternative 
diagnosis (n=24; 30.0%), followed by stress-related or 
somatoform symptoms (n=16; 20.0%) and syncope (n=9; 
11.3%; Table 3).
The EDCT classified 155 (75.2%) as TIA or minor stroke. 
There were 2 false negative cases (1.6% of TIA/minor stroke), 
that is, cases that had no TIA/minor stroke according to the 
EDCT but were classified as a TIA by the panel. Both cases 
had diplopia as the primary symptom. These 2 participants 
with a false negative EDCT did not suffer from a recurrent 
cerebrovascular event (TIA nor stroke) during the 6-month 
follow-up period. Thirty-one cases (38.8% of those with an al-
ternative diagnosis) were false positive, that is, cases that ful-
filled the EDCT criteria but were judged as no TIA (or minor 
stroke) by the panel. The diagnoses among these 31 false pos-
itive patients are shown in Table 4.
Table 5 shows an overview of the diagnostic accuracy of 
the EDCT. The original EDCT had a sensitivity of 98.4% (95% 
CI, 94.4–99.8) and a specificity of 61.3% (95% CI, 49.7–71.9). 
Negative and positive predictive values were 96.1% (95% CI, 
86.0–99.0) and 80.0% (95% CI, 75.2–84.1), respectively.
Reassessment of the EDCT after modification of the 
C-criterion resulted in 10 less false positive patients (21 instead 
of 31). These included 9 patients diagnosed with migraine with 
Table 2. Characteristics of 206 Patients Suspected of TIA by the General Practitioner, According to Those With a Final Diagnosis of 






Age, y; mean (SD) 67.7 (13.7) 71.4 (12.0) 62.0 (14.2) <0.01
Male sex, n (%) 112 (54.4) 69 (54.8) 43 (53.8) 0.89
Cardiovascular risk factors
 BMI, kg/m2; mean (SD) 25.7 (4.0) 25.7 (4.2) 25.6 (3.8) 0.85
 Smoking, n (%)
   Current smoker 38 (18.5) 18 (14.3) 20 (25.0) 0.05
   Former smoker 87 (42.2) 58 (46.0) 29 (36.3) 0.17
   Never smoked 81 (39.3) 50 (39.7) 31 (38.7) 0.89
 First degree relatives with CVD <65 y, n (%) (n=204) (n=125) (n=79)  
   0 127 (62.3) 84 (67.2) 43 (54.4) 0.07
   1 59 (28.9) 29 (23.2) 30 (38.0) 0.02
   ≥2 18 (8.8) 12 (9.6) 6 (7.6) 0.62
 Hypertension, n (%) 121 (59) 84 (66.7) 36 (45.0) <0.01
 Diabetes mellitus, n (%) 27 (13) 18 (14.3) 8 (10.0) 0.37
 Hyperlipidemia, n (%) 85 (42) 58 (46.0) 27 (33.8) 0.08
Medical history
  Previous cerebrovascular event, n (%) 51 (24.8) 35 (27.8) 16 (20.0) 0.21
   TIA 31 (15.0) 22 (17.5) 9 (11.3) 0.22
   Ischemic stroke 22 (11) 15 (11.9) 7 (8.8) 0.48
   Hemorrhagic stroke 7 (3) 5 (4.0) 2 (2.5) 0.57
  Previous (other) cardiovascular disease, 
n (%)
54 (26) 43 (34.1) 11 (13.8) <0.01
   Angina pectoris 13 (6) 12 (9.5) 1 (1.3) 0.02
   Myocardial infarction 13 (6) 13 (10.3) 0 (0.0) <0.01
   Peripheral artery disease 5 (2) 4 (3.2) 1 (1.3) 0.38
   Previous vascular surgery 23 (11) 19 (15.1) 4 (5.0) 0.03
   Renal insufficiency 16 (8) 11 (8.7) 5 (6.3) 0.52
   Atrial fibrillation 21 (10) 15 (11.9) 6 (7.5) 0.31
 History of migraine, n (%) 23 (11) 9 (7.1) 14 (17.5) 0.02
 History of epilepsy, n (%) 2 (1) 2 (1.6) 0 (0.0) 0.26
P Values were calculated using t tests for continuous variables and χ2 tests for categorical variables. BMI indicates body mass 
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aura, and 1 with stress-related/somatoform symptoms. The 
number of 2 false negative patients remained unchanged. The 
modified EDCT had a specificity of 73.8% (95% CI, 62.7–
83.0) and a sensitivity of 98.4% (95% CI, 94.4–99.8). The 
negative and positive predictive values were 96.7% (95% CI, 
86.0–99.0) and 85.5% (95% CI, 80.3–89.5), respectively.
Separate analyses of the 22 patients with a minor dis-
abling stroke did not substantially change the results (data not 
shown).
To assess interobserver variability, a second researcher (Dr 
Dolmans) also scored the EDCT for all false positive and neg-
ative cases (according to the assessment of the first researcher, 
D. Veluponnar) and a 20% random sample of all 206 patients. 
For the modified EDCT, there was agreement on the 2 false 
negative cases and the random sample and disagreement on 
1/22 false positive cases. A third researcher (Dr Kapelle) 
assessed the modified EDCT of the false positive and negative 
cases and came to the same results (100% agreement) as the 
second researcher.
Discussion
This first evaluation of the diagnostic accuracy of the EDCT in 
patients suspected of TIA demonstrates that the criteria have 
an excellent sensitivity (98.4%) and negative predictive value 
(96.1%). Moreover, modification of the EDCT by rephrasing 
the C-criteria resulted in a similar negative predictive value 
but in an increase in positive predictive value.
In the primary care setting, it is most valuable if a tool 
can safely exclude a TIA, which requires a high negative pre-
dictive value. If a GP would use the modified EDCT in 100 
patients suspected of TIA (with a prior chance of a TIA/minor 
stroke of 61%), 71 patients would be referred to a TIA service 
and as a result 60 confirmed as TIA and 11 would receive 
another final diagnosis after evaluation by the neurologist. 
Among the 29 patients in whom the GP would make another 
diagnosis, only 1 patient would wrongly not receive the diag-
nosis TIA. Both false negative cases in our study had diplopia, 
which could mean that the EDCT is more reliable to diagnose 
a TIA in the anterior than in the posterior circulation.
Two previous diagnostic scores that aim to facilitate cli-
nicians were developed based on regression analysis. The 
Dawson score consists of 9 determinants, including age and 
history of hypertension, supplemented with 7 symptoms.3 
The Diagnosis of TIA (DOT) score consists of 17 deter-
minants, including age, history of hypertension, history 
of or actual atrial fibrillation, supplemented with 14 spe-
cific symptoms.4 Both the Dawson and the DOT scores are 
not widely used and have not been established as a useful 
tool in clinical practice nor in research. The Dawson score 
had poor diagnostic value when applied by GPs (c-statistic 
0.70).5 The DOT score performed better in a direct compar-
ison with the Dawson score in a cohort of 525 suspected 
TIA patients seen at a British TIA service (c-statistic 0.89 
[0.85–0.92] versus 0.83 [0.79–0.87]).4 However, this com-
parison was performed in the derivation cohort of the DOT 
score and, therefore, very likely overestimates the perfor-
mance of the DOT score. Comparing our results with these 
studies and considering that the EDCT is just based on 
clinical experience, the overall discriminative ability of the 
EDCT in this external validation is remarkably high.
One might argue that a purely clinical score is not neces-
sary anymore in the modern era of sensitive neuroradiological 
methods such as diffusion-weighted magnetic resonance im-
agine or perfusion computed tomography-scanning.9,10 This is 
true in a hospital setting in developed countries, but imaging 
cannot always help to distinguish between TIA and the most 
common mimics. In addition, it does not apply at all in a pri-
mary care setting or in non-Western countries.
In the current study, we found a lower specificity of the 
EDCT than in the first study in which he EDCT was tested 
Table 3. Definite Diagnoses in 80 Patients With No TIA or Minor Stroke 
According to the Expert Panel
Diagnoses n (%)
Migraine with aura 24 (30.0)
Stress-related/somatoform 16 (20.0)
Syncope (reflex syncope/orthostatic hypotension) 9 (11.2)
TNA 7 (8.8)
Vestibular syndrome 5 (6.2)
Peripheral neuropathy 2 (2.5)
Cranial nerve palsy 2 (2.5)
Ophthalmic 2 (2.5)
Other diagnoses 7 (8.8)
  Epileptic seizure; subdural hematoma; pituitary  
  Adenoma; encephalopathy; retinal spasms; sleep  
  Phenomena; amyloid spell in cerebral amyloid  
  Angiopathy  
Unclear 6 (7.5)
Total 80
Transient neurological attack (TNA), defined as a transient episode of 
nonfocal neurological symptoms not fulfilling criteria for a transient ischemic 
attack (TIA) but lacking a clear alternative diagnosis. 
Table 4. Final Diagnosis in Those Patients With a False Positive Test Outcome 
of the Original EDCT and the Modified EDCT
Diagnosis
EDCT Modified EDCT
n (%) n (%)
Migraine with aura 13 (41.9) 4 (19.0)
Stress-related/somatoform 8 (25.8) 7 (33.3)
Peripheral neuropathy 2 (6.5) 2 (9.5)
TNA 1 (0.4) 1 (4.8)
Epilepsy 1 (0.4) 1 (4.8)
Syncope 1 (0.4) 1 (4.8)
Unclear 1 (0.4) 1 (4.8)
Other diagnoses* 4 (12.9) 4 (19.0)
Total 31 21
*Including abducens nerve palsy (n=1), encephalopathy (n=1), subdural 
hematoma (n=1), and vasospastic amaurosis fugax (n=1). EDCT indicates 
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in separate cohorts of patients with migraine with aura or 
with a TIA. Testing EDCT in a large cohort of patients with 
migraine with aura including many who had aura without 
headache showed a specificity of 95%, whereas in the pre-
sent study migraine was the most common false positive 
diagnosis. This difference can be explained by the fact that 
the patients with migraine in the MIND-TIA study were 
all initially suspected of a TIA by the GP and could there-
fore be considered to be more profound mimics of TIA. 
The quality of the collected information about characteris-
tics of migraine might have been better if the investigator 
would have had the EDCT at hand during data collection. 
This should be tested in further prospective studies. In the 
current form, EDCT is excellent for screening patients for 
research projects because of a very high sensitivity. Before 
inclusion in TIA trials, the diagnosis must, however, be re-
fined by expert evaluation.
Our study is the first to assess the EDCT among patients 
suspected of TIA by their GP. Strong points are the stan-
dardized way of collecting the required information and the 
completeness of data and the standardized way in which we 
assessed the TIA diagnosis by an expert panel. The use of an 
expert panel as the reference standard can, however, also be 
criticized. Although the panel consisted of experienced neu-
rologists, they had to make a diagnosis on the basis of writ-
ten information and did not speak to the patients themselves. 
One might also argue that neurologists on a regular basis dis-
agree about the diagnosis of TIA.2 However, in the absence 
of better alternatives, we feel that the use of consensus meet-
ings by a panel of experts is the best available option for the 
reference standard. Initial history taking was performed by a 
trained nurse and not by a medical specialist. This is different 
from most clinical practices, but a standardized questionnaire 
guaranteed objective and straightforward information about 
the symptoms and signs of the patients. Another limitation of 
our study is that the modification of EDCT was based on our 
MIND-TIA data and that we also validated that score in the 
same dataset. Thus, another external validation in a larger co-
hort is needed.
Finally, the actual usability in clinical practice and the per-
formance of the score, and the modified score, when applied 
by GPs or physicians at an emergency department is unknown 
at this point. There may be differences between a structured 
nurse interview and everyday history taking by a GP or 
Emergency physician. We, therefore, recommend to perform 
an implementation study in primary care and emergency de-
partment setting as the final step before use in everyday prac-
tice by GPs.
In conclusion, this study showed that the original, and es-
pecially the proposed modified EDCT are easy to apply, and 
have excellent diagnostic properties in patients suspected of 
TIA in primary care. They could be a valuable diagnostic tool 
for use in primary care and emergency departments as well as 
being a valuable supplement in TIA clinics.
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